search icon
Join IDSAJOIN IDSA >> Go to MyIDSAGO TO MYIDSA >>
  • Print
  • ShareThis
  • Text Size
  • IDSA
  • IDSA Statement on FY2017 Omnibus Funding Legislation

    05/05/2017

    The Infectious Diseases Society of America (IDSA) is grateful to Congress for passing H.R. 244, the Consolidated Appropriations Act, with its support for valuable infectious disease programs that will help protect public health in the United States and around the world.  We are pleased that the legislation maintains the federal commitment to combating antimicrobial resistance across multiple agencies, boosts NIH research funding and provides funding for a new Emergency Reserve fund to respond to infectious disease outbreaks. The HIV Medicine Association’s statement on FY2017 funding for HIV research, treatment and prevention is available here.

    IDSA applauds language in the bill proposed by the Society urging CMS to undertake research necessary to update Evaluation and Management (E&M) codes—the codes used for the majority of ID physician compensation—to more precisely describe the cognitive work in these physician-patient encounters. 

    The bipartisan support for a $2 billion increase in NIH research funding will help to strengthen America’s role as the world leader in biomedical research and will allow us to move forward in the effort to develop new vaccines, diagnostics and antimicrobial drugs.  The funding will also allow The Fogarty International Center to continue to support international collaborations with U.S. institutions that empower developing countries to respond to infectious disease outbreaks at their source.

    The CDC plays an essential role in keeping America safe from infectious diseases threats, including outbreaks and other emergencies, as well as everyday threats such as vaccine-preventable illnesses and antimicrobial resistance. IDSA is appreciative of funding for key CDC programs such as the $8 million increase in its global health programs and continued support for the agency’s public health preparedness and response programs and Biomedical Advanced Research and Development Authority (BARDA). However, IDSA was disappointed to see a $3.9 million cut in funding for the Section 317 Immunization program, given the important role vaccines play in preventing infectious disease outbreaks.

    Infectious diseases do not respect borders. The legislation demonstrates that Congress recognizes the importance of combating infectious diseases abroad by funding global health programs at the United States Agency for International Development, with increases for malaria efforts and tuberculosis activities.

    Finally, while IDSA appreciates resources for infectious diseases included in the FY2017 omnibus bill, we remain extremely concerned about the drastic reductions in funding for many of NIH, CDC and USAID programs proposed in the administration’s FY2018 budget blueprint. As Congress moves forward with the FY2018 appropriations process, IDSA looks forward to working with Congress to ensure full funding for these efforts to protect the health and safety of individuals and families in America and around the world.

| HIVMA | Contact Us

© Copyright IDSA 2017 Infectious Diseases Society of America

Full Site Mobile Site